Cat.#: ACPP-1249
Despition | TMPRSS2 Blocking Peptide for Immunocompeition, Immunodepletion |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1336 | Estrogen Receptor alpha Blocking Peptide (AC1336) | 250 µg | inquiry |
ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
ACPP-1837 | Rat SCGN Protein (AC1837) | 2 µg | inquiry |
ACPP-1687 | Mouse Visfatin Protein (AC1687) | 5 µg | inquiry |
ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
ACPP-1241 | Dopamine Receptor D4 Blocking Peptide (AC1241) | 250 µg | inquiry |
ACPP-1133 | Synthetic Nanodisc Human OR52D1 Protein (AC1133) | 10 µg | inquiry |
ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
ACPP-1184 | MSX1 Blocking Peptide (AC1184) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.